TIVOZANIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where TIVOZANIB was used for Neoplasm.
Most Reported Side Effects for TIVOZANIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 291 | 20.9% | 9 | 36 |
| Diarrhoea | 177 | 12.7% | 7 | 28 |
| Blood pressure increased | 144 | 10.3% | 6 | 21 |
| Nausea | 132 | 9.5% | 8 | 24 |
| Decreased appetite | 127 | 9.1% | 7 | 32 |
| Disease progression | 121 | 8.7% | 12 | 17 |
| Dysphonia | 109 | 7.8% | 3 | 13 |
| Death | 89 | 6.4% | 89 | 15 |
| Asthenia | 80 | 5.7% | 5 | 17 |
| Off label use | 73 | 5.2% | 3 | 8 |
| Pain | 68 | 4.9% | 5 | 16 |
| Hypertension | 66 | 4.7% | 5 | 12 |
| Vomiting | 63 | 4.5% | 3 | 20 |
| Dyspnoea | 52 | 3.7% | 4 | 22 |
| Constipation | 51 | 3.7% | 2 | 14 |
Other Indications for TIVOZANIB
Renal cell carcinoma (1,258)
Metastatic renal cell carcinoma (49)
Renal cancer (34)
Product used for unknown indication (18)
Clear cell renal cell carcinoma (7)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)